Phase III clinical trials: objectives, hypothesis and design
Phase II/III study of intraperitoneal chemotherapy
Phase II Trial of Continuous Dose-Intense
Phase II Trial of Combined Modality Therapy plus
Phase II trial of 5-fluorouracil plus eniluracil in patients with
Phase II study of weekly paclitaxel/carboplatin in
Phase II Study of Paclitaxel in Patients With
Phase II Study of Oxaliplatin in Platinum-Resistant and
PHASE II STUDY OF NEO-ADJUVANT PACLITAXEL
Phase II study of mitoxantrone and ketoconazole for hormone
Phase II Study of Imatinib in Patients with Small Cell Lung Cancer
Phase II study of capecitabine and the oral mTOR inhibitor
Phase II randomized trial of ixabepilone administered
Phase II Feasibility Trial Incorporating Bevacizumab into Dose
Phase II designs in Oncology
Phase II Clinical Trials: Issues and Practices
Phase I/II Study of Dianhydrogalactitol in Patients with Recurrent
Phase I/II Study of 19-nor-1A-25-Dihydroxyvitamin D2 (Paricalcitol
phase i trial of yeast
Phase I Trial of theTrifunctional Anti-HER2 В Anti
Phase I trial designs (Blatchford)